Medication info

Feminentin Neo Syrup [Amoxicillin-Clavulanate Potassium (14:1)]

Prescription medicationSyrupOralExpired
Ingredient · strength
Amoxicillin Hydrate›54.55g / 100gDilute Potassium Clavulanate›3.9g / 100g
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
A syrup form that is a white to pale yellow powder with a peculiar smell, used after dissolving.
Packaging
50 milliliters/bottle
Approval status
Expired

MFDS item code 201907986 · Notified 2019.11.19

This product's status changed to Expired on 2024.11.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children
Who takes it
Adults · Children
Adult dose
○ Adults: There is no experience with the use of this medication in adults. ○ Patients with hepatic impairment: Use this medication with caution in patients with hepatic impairment and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medication at the start of a meal. Administration at the start of a meal increases the absorption of potassium clavulanate.
Child dose
○ Pediatric patients 3 months of age and older: The recommended dose of this medication, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day divided every 12 hours; administer for 10 days for acute otitis media and 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medication in pediatric patients weighing 40kg or more.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children

  • Recurrent acute otitis media
  • persistent acute otitis media
  • recurrent acute sinusitis
View approved original text

This medication is used to treat recurrent or persistent acute otitis media and acute sinusitis in pediatric patients. It is particularly effective in children under 2 years old who have received antibiotics for acute otitis media or sinusitis within the last 3 months or who attend daycare. It can counteract major pathogens such as Streptococcus pneumoniae, Haemophilus influenzae (including beta-lactamase producing strains), and Moraxella catarrhalis. This medication helps treat infections and improves symptoms.

How to take

Adult dose

○ Adults: There is no experience with the use of this medication in adults. ○ Patients with hepatic impairment: Use this medication with caution in patients with hepatic impairment and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medication at the start of a meal. Administration at the start of a meal increases the absorption of potassium clavulanate.

Child dose

○ Pediatric patients 3 months of age and older: The recommended dose of this medication, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day divided every 12 hours; administer for 10 days for acute otitis media and 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medication in pediatric patients weighing 40kg or more.

Precautions

This medication contains the artificial sweetener aspartame which breaks down into phenylalanine in the body. Therefore, it should not be used by patients with phenylketonuria, a genetic disorder that requires limited intake of phenylalanine. Patients who have a history of allergy to the components of this medication or penicillin and cephalosporin antibiotics, patients with infectious mononucleosis or lymphocytic leukemia, patients with a history of liver dysfunction or jaundice due to this medication or penicillin, and patients with genetic problems such as lactose intolerance or galactose intolerance should not be administered this medication. Patients with poor liver function or moderate to severe renal impairment should be cautious when using this medication, as well as allergic individuals, those who have difficulty taking medication orally, the elderly, and patients in poor general condition should be administered this medication with caution. Additionally, patients with gastrointestinal diseases accompanied by vomiting or diarrhea should be careful as the absorption of the drug may not be adequate. This medication may cause mostly mild or temporary side effects, with the most common side effects being skin rash, diarrhea, and vomiting. Rarely, liver function abnormalities, severe allergic reactions, blood disorders, renal impairment, and central nervous system abnormalities may occur, so any abnormal symptoms should be consulted with a physician immediately. It is important to regularly monitor and observe kidney and liver function, as well as blood status, in patients who use this medication for an extended period or in high doses. Moreover, patients who have had hypersensitivity to penicillin antibiotics should inform medical personnel before administering this medication. This medication should only be used for the treatment of bacterial infections and will not be effective against viral infections. Even if symptoms improve during treatment, the prescribed duration of medication should be continued, and stopping or skipping doses can reduce treatment efficacy and risk the development of resistant bacteria. Before taking, the medication should be shaken well, and after preparation, it should be stored in the refrigerator and used within 7 days. Keep out of reach of children and store in a cool, dry place below 25 degrees Celsius for better efficacy. In cases of overdose, symptoms such as gastrointestinal symptoms, electrolyte abnormalities, rashes, and neurological abnormalities may occur, and medical personnel should be notified immediately, and appropriate treatment should be undertaken if necessary. Additionally, this medication may interact with other drugs, so inform medical personnel about any current medications being taken, especially when used with anticoagulants or certain antibiotics.

Side effects

Contact dermatitis, diaper rash, diarrhea, vomiting, moniliasis, rash, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, anorexia, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, loose stools, xerostomia, acute pancreatitis, candidiasis, antibiotic-associated colitis, bloody stools, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, eosinophilia, drug reaction (DRESS), angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, reversible leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vulvar pruritus, burning sensation, increased secretion, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, oral edema, symptoms of vitamin K deficiency, symptoms of vitamin B group deficiency, dental discoloration, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, gastric pain, abdominal pain, hyperactivity, drowsiness, interstitial nephritis, renal impairment due to diabetes, crystalluria, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also advisable to place it in a cool, dry place between 1 and 25 degrees Celsius. This will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

A syrup form that is a white to pale yellow powder with a peculiar smell, used after dissolving.

Package unit

50 milliliters/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.